Albany Molecular Research, Inc. (NASDAQ:AMRI)

CAPS Rating: 4 out of 5

The Company is a global chemistry-based drug discovery and development company focused on identifying and developing novel biologically active small molecules with applications in the drug market.

Recs

0
Player Avatar Brob84 (< 20) Submitted: 6/23/2007 1:22:57 PM : Outperform Start Price: $14.70 AMRI Score: -73.78

Growing by pharmaceutical development and licensing or partnership with large pharma corps.

Featured Broker Partners


Advertisement